SBIR/STTR Research Award

Non-Invasive Assay for Diagnosis and Treatment of Endometriosis

Award identifier 8f12f2e2c07560e52acad599ffa523311188af33a48f8a89a7082b33c2fd8b79Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$164,306

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Ribomed Biotechnologies, Inc.
Proposal award date
2019-01-01
Contract end date
2020-06-30
UEI
NRWMJLALNTY7
Solicitation number
HD19-006
Topic code
NICHD

Research abstract

Project Summary AbstractEndometriosis affects up toof women of reproductive age often causing painful symptoms and an increased risk of infertilityA major clinical problem is the lack of a noninvasive and early diagnostic procedureThe diagnostic gold standard is laparoscopic surgery and histology of the recovered lesionsThe goal of this Phase I project is to develop a noninvasive diagnostic test for endometriosis that focuses on early changes in DNA methylation identified from published biomarker discoveryAssays will be based on the MethylMeter platformA fragmented DNA sample will be fractionated into a methylated DNA fraction and an unmethylated DNA fraction with the use of magnetic beads bearing a methyl CpG binding domain proteinThe amount of a targeted biomarker in each fraction will be quantified by Coupled Abscription PCR SignalingCAPSCAPS combines target DNA amplification with signal amplificationAmplicons with linked promoters are created during the PCR stepThe promoters are then subjected to abortive transcription with an RNA polymeraseAbscriptaseto produce a uniform population ofnt long RNAs also known as abscriptsA fluorescent signal is created by each abscript by participating in the opening of a molecular beaconCAPS is more sensitive than qPCR because each amplicon generates multiple signals as opposed to oneAssays will be developed for methylation detection targeted to specific CpG islands and surrounding sequencesAssay development will involve the identification and validation of PCR primers taking into consideration additional sequence for the linked abortive promotersPCR conditions will be optimized to eliminate amplification bias against methylated versions of the targetsConditions for methylated DNA binding will be optimized for a minimum oftargetsPhase II will focus on the clinical validation of the individual target assays and the development of a diagnostic signatureProtocols for sample collection and processing also will be developed Project Narrative Endometriosis affectsof women of reproductive age carrying risks of reduced fertility and painful symptomsCurrently a surgical procedure is the only definitive diagnosticThis projects aims to develop an earlynoninvasive diagnostic based on aberrant DNA methylation in endometriosis

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

5 SBIR/STTR records share this UEI (2002–2019). Reported award amounts total $1,043,874. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.